Add Axona to Alzheimer’s disease management, including drug treatments, to address multiple aspects of the disease at the same time1
Diminished cerebral glucose metabolism (DCGM, also known as glucose hypometabolism) occurs early in the disease and correlates with symptoms and disease progression.2-6 During times of DCGM, the brain can use alternative fuel sources, such as ketone bodies, to produce cellular energy.7,8
Diminished cerebral glucose metabolism in Alzheimer’s disease3,4
Find out more about one of the earliest brain changes that occurs in Alzheimer’s disease.
Ketone bodies: the brain’s natural back-up fuel1,8
Find out how Axona can help during times of DCGM.
Axona is a prescription medical food that safely increases the concentration of ketone bodies in the blood. Adding Axona to Alzheimer’s disease management addresses different aspects of the disease at the same time and may further enhance memory and cognition.*1